Latest Breaking News On - Hillstream biopharma inc - Page 4 : comparemela.com

Short Interest in Hillstream BioPharma, Inc (NASDAQ:HILS) Decreases By 11 9%

Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 133,000 shares, a decline of 11.9% from the July 15th total of 150,900 shares. Approximately 2.2% of the company’s stock are sold short. […]

Hillstream biopharmaDawson jamesHillstream biopharma incCitadel advisorsHillstream biopharma company profileGeode capital managementGet free reportBiopharma stock downCapital managementJane street groupHillstream biopharma dailyNasdaq hils

Short Interest in Hillstream BioPharma, Inc (NASDAQ:HILS) Decreases By 11 9%

Short Interest in Hillstream BioPharma, Inc (NASDAQ:HILS) Decreases By 11 9%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Hillstream biopharmaDawson jamesCitadel advisorsHillstream biopharma company profileGeode capital managementHillstream biopharma incGet free reportBiopharma stock downStreet groupCapital managementHillstream biopharma daily

Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023

Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Randy milbyMinotaur therapeutics incExchange commissionHillstream biopharma incOmniab incCrystal bioscience incMinotaur therapeuticsAnnual sidoti micro cap virtual conferenceLooking statementscertainPrivate securities litigation reform actCrystal bioscienceRelations contactemailHillstream biopharma

Hillstream BioPharma (NASDAQ:HILS) Lowered to Neutral at Dawson James

Dawson James lowered shares of Hillstream BioPharma (NASDAQ:HILS – Free Report) from a buy rating to a neutral rating in a research note published on Monday, MarketBeat reports. Hillstream BioPharma Trading Down 4.3 % Shares of HILS stock opened at $0.38 on Monday. The firm has a fifty day simple moving average of $0.38 and […]

Dawson jamesHillstream biopharmaGeode capital managementHillstream biopharma incHillstream biopharma company profileCitadel advisorsFree reportBiopharma trading downGet free reportStreet groupCapital managementHillstream biopharma dailyNasdaq hils

Hillstream BioPharma, Inc (NASDAQ:HILS) Short Interest Down 23 6% in June

Hillstream BioPharma, Inc. (NASDAQ:HILS – Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 262,000 shares, a decline of 23.6% from the May 31st total of 343,000 shares. Based on an average trading volume of 644,900 shares, the […]

Hillstream biopharmaHillstream biopharma incCitadel advisorsGeode capital managementFree reportStreet groupHillstream biopharma daily